IV to oral switch: a novel viewpoint
J Antimicrob Chemother
.
2023 Oct 3;78(10):2603-2604.
doi: 10.1093/jac/dkad239.
Author
Abi Jenkins
1
Affiliation
1
Department of Pharmacy, University Hospitals Birmingham, Mindlesohn Way, Birmingham, B15 2WB, UK.
PMID:
37549305
DOI:
10.1093/jac/dkad239
No abstract available
MeSH terms
Administration, Intravenous
Administration, Oral
Anti-Bacterial Agents* / therapeutic use
Substances
Anti-Bacterial Agents